Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development. Recent groundbreaking scientific insights into the genetic causes and biological processes and pathways underlying neurodegenerative diseases offer an unprecedented opportunity for the discovery and development of effective medicines for Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases. Denali is applying deep scientific and drug development expertise to fully harvest the potential of these pathways to discover effective molecular therapeutics.